Article info

Download PDFPDF
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I–II endometrial cancer

Authors

  1. Address correspondence and reprint requests to: Thomas Hogberg, Department of Gynecologic Oncology, University Hospital, SE 581 85 Linkoping, Sweden. Email: thomas.hogberg{at}ibk.liu.se

Citation

HOGBERG T, FREDSTORP-LIDEBRING M, ALM P On behalf of the Southern Swedish Gynecologic Oncology Group, et al
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I–II endometrial cancer

Publication history

  • First published May 1, 2004.
Online issue publication 
May 01, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.